1. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
    Dharambir Kashyap et al, 2023, Frontiers in Genetics CrossRef
  2. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis
    Xiaolong Liu et al, 2020, The American Journal of the Medical Sciences CrossRef
  3. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype
    Patrick B. Thomas et al, 2021, PeerJ CrossRef

  4. Long Intergenic Non-Coding RNA LINC00922 Aggravates the Malignant Phenotype of Breast Cancer by Regulating the microRNA-424-5p/BDNF Axis


    Xin Yue et al, 2020, Cancer Management and Research CrossRef
  5. HLA-DPB1 genotype variants predict DP molecule cell surface expression and DP donor specific antibody binding capacity
    Yuxin Yin et al, 2024, Frontiers in Immunology CrossRef
  6. SLC16A1-AS1 enhances radiosensitivity and represses cell proliferation and invasion by regulating the miR-301b-3p/CHD5 axis in hepatocellular carcinoma
    Shenglin Pei et al, 2020, Environmental Science and Pollution Research CrossRef
  7. Simultaneous Enzyme-Free Detection of Multiple Long Noncoding RNAs in Cancer Cells at Single-Molecule/Particle Level
    Yan Zhang et al, 2021, Nano Letters CrossRef
  8. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression
    Zhi-wei Qiao et al, 2021, BMC Cancer CrossRef
  9. The current advances of lncRNAs in breast cancer immunobiology research
    Marco Antonio Fonseca-Montaño et al, 2023, Frontiers in Immunology CrossRef